Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis B: Advances in Screening, Diagnosis, and Clinical Management -- Volume 3
Volume 3 CME Connect The Journal SPECIALTY SITES Pathology & OTHER SITES Today CME Your 2008 CME Credits: Return to Pathology & More: -- Volume 3 CME Release

interTrend Partners With The San Francisco Hep B Free Campaign to Increase Awareness and Understanding of Hepatitis B
- The 'B a Hero' Campaign Will Be Launched in August - LONG BEACH, Calif., Aug. 28 /PRNewswire/ -- interTrend Communications, a full-service Asian American marketing communications agency, joined forces with The SF Hep B Free Campaign (The SF Hep B Free)

[Original articles] Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection
Extract not available.

UPDATES AND COMMENTARY RSS Feed

Hep C Treatment: Comparing the Pegylated Interferons
Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating their...

Vertex's Advanced Trial Could Change HCV Treatment
Hundreds of non-responders to interferon-ribavirin combination therapy will be enrolled in a late stage clinical trial for Vertex's telaprevir....

Silymarin Improves Quality of Life During Hepatitis C Treatment
Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin....

Cost-Effectiveness of Ultrasound-Guided Liver Biopsy

table 1

table  1.   Complication Rates of "Blind" Liver Biopsy


Study Year n Complications n (%)

Inpatient
  Terry10 1952 10,600 24* (0.32)
  Thaler12 1964 23,382 27 (0.12)
  Lindner13 1967 79,381 273 (0.34)
  Knauer1 1978 1,067 5 (0.47)
  Sherlock et al.14 1984 6,379 40 (0.63)
  Piccinino et al.11 1986 68,276 147 (0.22)
189,085 516 (0.27)
Outpatient liver biopsy
  Rosson et al.15 1972 63 0 (0)
  Ali et al.16 1978 67 2 (3)
  Knauer1 1978 107 1 (0.9)
  Perrault et al.2 1978 829 44 (5.4)
  Westaby et al.17 1980 200 6 (3)
  Sherlock et al.14 1984 55 1 (1.8)
  Wright18 1991 94 1 (1.1)
  Janes and Lindor4 1993 405 13 (3.2)
  Garcia-Tsao and Boyer19 1993 346 5 (1.4)
  Lindor et al.8 1996 413 9 (2.2)
2579 82 (3.2)

* Among 7532 cases.

Return To Article

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 29 Aug 2008